Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism
Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons w...
Saved in:
Published in | Journal of medical Internet research Vol. 23; no. 12; p. e28021 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Gunther Eysenbach MD MPH, Associate Professor
07.12.2021
JMIR Publications |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons with ALS (PALS) face difficulty finding and enrolling in research studies for which they are eligible.
The aim of this study was to describe how the federal Agency for Toxic Substances and Disease Registry's (ATSDR) National ALS Registry is linking PALS to scientists who are conducting research, clinical trials, and epidemiological studies.
Through the Registry's online research notification mechanism (RNM), PALS can elect to be notified about new research opportunities. This mechanism allows researchers to upload a standardized application outlining their study design and objectives, and proof of Institutional Review Board approval. If the application is approved, ATSDR queries the Registry for PALS meeting the study's specific eligibility criteria, and then distributes the researcher's study material and contact information to PALS via email. PALS then need to contact the researcher directly to take part in any research. Such an approach allows ATSDR to protect the confidentiality of Registry enrollees.
From 2013 to 2019, a total of 46 institutions around the United States and abroad have leveraged this tool and over 600,000 emails have been sent, resulting in over 2000 patients conservatively recruited for clinical trials and epidemiological studies. Patients between the ages of 60 and 69 had the highest level of participation, whereas those between the ages of 18 and 39 and aged over 80 had the lowest. More males participated (4170/7030, 59.32%) than females (2860/7030, 40.68%).
The National ALS Registry's RNM benefits PALS by connecting them to appropriate ALS research. Simultaneously, the system benefits researchers by expediting recruitment, increasing sample size, and efficiently identifying PALS meeting specific eligibility requirements. As more researchers learn about and use this mechanism, both PALS and researchers can hasten research and expand trial options for PALS. |
---|---|
AbstractList | Background: Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons with ALS (PALS) face difficulty finding and enrolling in research studies for which they are eligible. Objective: The aim of this study was to describe how the federal Agency for Toxic Substances and Disease Registry’s (ATSDR) National ALS Registry is linking PALS to scientists who are conducting research, clinical trials, and epidemiological studies. Methods: Through the Registry’s online research notification mechanism (RNM), PALS can elect to be notified about new research opportunities. This mechanism allows researchers to upload a standardized application outlining their study design and objectives, and proof of Institutional Review Board approval. If the application is approved, ATSDR queries the Registry for PALS meeting the study’s specific eligibility criteria, and then distributes the researcher’s study material and contact information to PALS via email. PALS then need to contact the researcher directly to take part in any research. Such an approach allows ATSDR to protect the confidentiality of Registry enrollees. Results: From 2013 to 2019, a total of 46 institutions around the United States and abroad have leveraged this tool and over 600,000 emails have been sent, resulting in over 2000 patients conservatively recruited for clinical trials and epidemiological studies. Patients between the ages of 60 and 69 had the highest level of participation, whereas those between the ages of 18 and 39 and aged over 80 had the lowest. More males participated (4170/7030, 59.32%) than females (2860/7030, 40.68%). Conclusions: The National ALS Registry’s RNM benefits PALS by connecting them to appropriate ALS research. Simultaneously, the system benefits researchers by expediting recruitment, increasing sample size, and efficiently identifying PALS meeting specific eligibility requirements. As more researchers learn about and use this mechanism, both PALS and researchers can hasten research and expand trial options for PALS. Background Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons with ALS (PALS) face difficulty finding and enrolling in research studies for which they are eligible. Objective The aim of this study was to describe how the federal Agency for Toxic Substances and Disease Registry’s (ATSDR) National ALS Registry is linking PALS to scientists who are conducting research, clinical trials, and epidemiological studies. Methods Through the Registry’s online research notification mechanism (RNM), PALS can elect to be notified about new research opportunities. This mechanism allows researchers to upload a standardized application outlining their study design and objectives, and proof of Institutional Review Board approval. If the application is approved, ATSDR queries the Registry for PALS meeting the study’s specific eligibility criteria, and then distributes the researcher’s study material and contact information to PALS via email. PALS then need to contact the researcher directly to take part in any research. Such an approach allows ATSDR to protect the confidentiality of Registry enrollees. Results From 2013 to 2019, a total of 46 institutions around the United States and abroad have leveraged this tool and over 600,000 emails have been sent, resulting in over 2000 patients conservatively recruited for clinical trials and epidemiological studies. Patients between the ages of 60 and 69 had the highest level of participation, whereas those between the ages of 18 and 39 and aged over 80 had the lowest. More males participated (4170/7030, 59.32%) than females (2860/7030, 40.68%). Conclusions The National ALS Registry’s RNM benefits PALS by connecting them to appropriate ALS research. Simultaneously, the system benefits researchers by expediting recruitment, increasing sample size, and efficiently identifying PALS meeting specific eligibility requirements. As more researchers learn about and use this mechanism, both PALS and researchers can hasten research and expand trial options for PALS. Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons with ALS (PALS) face difficulty finding and enrolling in research studies for which they are eligible. The aim of this study was to describe how the federal Agency for Toxic Substances and Disease Registry's (ATSDR) National ALS Registry is linking PALS to scientists who are conducting research, clinical trials, and epidemiological studies. Through the Registry's online research notification mechanism (RNM), PALS can elect to be notified about new research opportunities. This mechanism allows researchers to upload a standardized application outlining their study design and objectives, and proof of Institutional Review Board approval. If the application is approved, ATSDR queries the Registry for PALS meeting the study's specific eligibility criteria, and then distributes the researcher's study material and contact information to PALS via email. PALS then need to contact the researcher directly to take part in any research. Such an approach allows ATSDR to protect the confidentiality of Registry enrollees. From 2013 to 2019, a total of 46 institutions around the United States and abroad have leveraged this tool and over 600,000 emails have been sent, resulting in over 2000 patients conservatively recruited for clinical trials and epidemiological studies. Patients between the ages of 60 and 69 had the highest level of participation, whereas those between the ages of 18 and 39 and aged over 80 had the lowest. More males participated (4170/7030, 59.32%) than females (2860/7030, 40.68%). The National ALS Registry's RNM benefits PALS by connecting them to appropriate ALS research. Simultaneously, the system benefits researchers by expediting recruitment, increasing sample size, and efficiently identifying PALS meeting specific eligibility requirements. As more researchers learn about and use this mechanism, both PALS and researchers can hasten research and expand trial options for PALS. BackgroundResearchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include obtaining sufficient statistical power as well as meeting eligibility requirements such as age, sex, and study proximity. Similarly, persons with ALS (PALS) face difficulty finding and enrolling in research studies for which they are eligible. ObjectiveThe aim of this study was to describe how the federal Agency for Toxic Substances and Disease Registry’s (ATSDR) National ALS Registry is linking PALS to scientists who are conducting research, clinical trials, and epidemiological studies. MethodsThrough the Registry’s online research notification mechanism (RNM), PALS can elect to be notified about new research opportunities. This mechanism allows researchers to upload a standardized application outlining their study design and objectives, and proof of Institutional Review Board approval. If the application is approved, ATSDR queries the Registry for PALS meeting the study’s specific eligibility criteria, and then distributes the researcher’s study material and contact information to PALS via email. PALS then need to contact the researcher directly to take part in any research. Such an approach allows ATSDR to protect the confidentiality of Registry enrollees. ResultsFrom 2013 to 2019, a total of 46 institutions around the United States and abroad have leveraged this tool and over 600,000 emails have been sent, resulting in over 2000 patients conservatively recruited for clinical trials and epidemiological studies. Patients between the ages of 60 and 69 had the highest level of participation, whereas those between the ages of 18 and 39 and aged over 80 had the lowest. More males participated (4170/7030, 59.32%) than females (2860/7030, 40.68%). ConclusionsThe National ALS Registry’s RNM benefits PALS by connecting them to appropriate ALS research. Simultaneously, the system benefits researchers by expediting recruitment, increasing sample size, and efficiently identifying PALS meeting specific eligibility requirements. As more researchers learn about and use this mechanism, both PALS and researchers can hasten research and expand trial options for PALS. |
Author | Paganoni, Sabrina Horton, D Kevin Mitsumoto, Hiroshi Bedlack, Richard Stanley Mehta, Paul Berry, James D Larson, Theodore Raymond, Jaime Han, Moon Kwon |
AuthorAffiliation | 3 Spaulding Rehabilitation Hospital Harvard Medical School Boston, MA United States 4 Department of Neurology Columbia University College of Physicians and Surgeons New York City, NY United States 2 Sean M Healey & AMG Center for ALS Massachusetts General Hospital Boston, MA United States 5 Department of Neurology Duke University School of Medicine Durham, NC United States 1 Agency for Toxic Substances and Disease Registry Centers for Disease Control and Prevention Atlanta, GA United States |
AuthorAffiliation_xml | – name: 5 Department of Neurology Duke University School of Medicine Durham, NC United States – name: 4 Department of Neurology Columbia University College of Physicians and Surgeons New York City, NY United States – name: 1 Agency for Toxic Substances and Disease Registry Centers for Disease Control and Prevention Atlanta, GA United States – name: 3 Spaulding Rehabilitation Hospital Harvard Medical School Boston, MA United States – name: 2 Sean M Healey & AMG Center for ALS Massachusetts General Hospital Boston, MA United States |
Author_xml | – sequence: 1 givenname: Paul orcidid: 0000-0002-0796-8861 surname: Mehta fullname: Mehta, Paul organization: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, United States – sequence: 2 givenname: Jaime orcidid: 0000-0002-5594-6931 surname: Raymond fullname: Raymond, Jaime organization: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, United States – sequence: 3 givenname: Moon Kwon orcidid: 0000-0002-2246-3618 surname: Han fullname: Han, Moon Kwon organization: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, United States – sequence: 4 givenname: Theodore orcidid: 0000-0003-4719-4829 surname: Larson fullname: Larson, Theodore organization: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, United States – sequence: 5 givenname: James D orcidid: 0000-0003-0898-6081 surname: Berry fullname: Berry, James D organization: Sean M Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, United States – sequence: 6 givenname: Sabrina orcidid: 0000-0003-0505-1168 surname: Paganoni fullname: Paganoni, Sabrina organization: Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, United States – sequence: 7 givenname: Hiroshi orcidid: 0000-0001-6259-8923 surname: Mitsumoto fullname: Mitsumoto, Hiroshi organization: Department of Neurology, Columbia University College of Physicians and Surgeons, New York City, NY, United States – sequence: 8 givenname: Richard Stanley orcidid: 0000-0003-4666-7495 surname: Bedlack fullname: Bedlack, Richard Stanley organization: Department of Neurology, Duke University School of Medicine, Durham, NC, United States – sequence: 9 givenname: D Kevin orcidid: 0000-0001-6214-6687 surname: Horton fullname: Horton, D Kevin organization: Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, United States |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34878988$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkt1u1DAQhSNURH_oKyBLCMHNgh07jsNFpdVSoNJSULeIS8txxhuvknixnUr7bjwczm6pWq48mvl0ZnR8TrOjwQ2QZecEv89JxT_kAufkWXZCGBUzIUpy9Kg-zk5D2GCcY1aRF9kxZaIUlRAn2Z8b0H60sYchImfQDxVtKgP6ZWOL5v3ORe-2rdVoqSJ41aGV7sC7YAMyzqNFZwerU_vWW9UFpIYGXW5tA711nVvvR6s4NhbCR_QJgvZ2G-0d7Ju7aWNsAV2nrW5I6Hy5QjewtiH63duQygDK6xZdu2hNEpsw9A10qwYb-pfZc5OWwvn9e5b9_Hx5u_g6W37_crWYL2eaFWWcFbThvGYMl6WoOTaqoQygJiw3QuQKg9Ec1xVwjhlmrKoYFEQ0QJhiIJqcnmVXB93GqY3cetsrv5NOWblvOL-WykebjJFFVdaYAGbGMEZ5WXFjACtKdInzBtdJ6-KgtR3rHhqdzE6uPhF9OhlsK9fuTgpeUSJ4Enh3L-Dd7xFClL0NGrpODeDGIHOOBStyUk7o6__QjRt98nmiSFFQWuCJenOgdPrW4ME8HEOwnLIl99lK3KvHlz9Q_8JE_wKBRM2m |
CitedBy_id | crossref_primary_10_1186_s13643_024_02533_0 crossref_primary_10_1007_s40615_024_02047_4 crossref_primary_10_1016_j_brs_2023_11_008 crossref_primary_10_1002_acn3_51660 crossref_primary_10_1097_MS9_0000000000000814 |
Cites_doi | 10.1111/1753-6405.12868 10.1136/bmj.d3662 10.15585/mmwr.mm6746a1 10.1080/17482960802195913 10.1080/21678421.2017.1406953 10.1002/mus.880180711 10.1016/S1474-4422(18)30091-7 10.3109/17482968.2010.484494 10.1159/000351153 10.3389/fneur.2017.00521 10.1212/wnl.0b013e3182a823e0 10.1212/WNL.0000000000006855 10.1002/mus.24421 10.15585/mmwr.ss6508a1 10.1002/mus.26921 10.1002/mus.27091 10.1358/dot.2018.54.6.2828189 10.1212/wnl.0000000000008620 10.1038/s41581-020-00336-9 10.3389/fnagi.2017.00068 10.1016/j.cct.2014.12.012 |
ContentType | Journal Article |
Copyright | Paul Mehta, Jaime Raymond, Moon Kwon Han, Theodore Larson, James D Berry, Sabrina Paganoni, Hiroshi Mitsumoto, Richard Stanley Bedlack, D Kevin Horton. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.12.2021. 2021. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Paul Mehta, Jaime Raymond, Moon Kwon Han, Theodore Larson, James D Berry, Sabrina Paganoni, Hiroshi Mitsumoto, Richard Stanley Bedlack, D Kevin Horton. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.12.2021. 2021 |
Copyright_xml | – notice: Paul Mehta, Jaime Raymond, Moon Kwon Han, Theodore Larson, James D Berry, Sabrina Paganoni, Hiroshi Mitsumoto, Richard Stanley Bedlack, D Kevin Horton. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.12.2021. – notice: 2021. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Paul Mehta, Jaime Raymond, Moon Kwon Han, Theodore Larson, James D Berry, Sabrina Paganoni, Hiroshi Mitsumoto, Richard Stanley Bedlack, D Kevin Horton. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.12.2021. 2021 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QJ 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA ALSLI AZQEC BENPR CCPQU CNYFK COVID DWQXO E3H F2A FYUFA GHDGH K9. KB0 M0S M1O NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.2196/28021 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Applied Social Sciences Index & Abstracts (ASSIA) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central Social Science Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Central Essentials ProQuest Central ProQuest One Community College Library & Information Science Collection Coronavirus Research Database ProQuest Central Library & Information Sciences Abstracts (LISA) Library & Information Science Abstracts (LISA) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Library Science Database Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Library and Information Science Abstracts (LISA) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Applied Social Sciences Index and Abstracts (ASSIA) ProQuest Central China ProQuest Central ProQuest Library Science Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Library & Information Science Collection Social Science Premium Collection ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Library & Information Science |
EISSN | 1438-8871 |
EndPage | e28021 |
ExternalDocumentID | oai_doaj_org_article_597b01e04ff4436796ffe0a31c702d0b 10_2196_28021 34878988 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GroupedDBID | --- .4I .DC 29L 2WC 36B 53G 5GY 5VS 77K 7RV 7X7 8FI 8FJ AAFWJ AAKPC AAWTL ABDBF ABIVO ABUWG ACGFO ADBBV AEGXH AENEX AFKRA AFPKN AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AOIJS BAWUL BCNDV BENPR CCPQU CGR CNYFK CS3 CUY CVF DIK DU5 DWQXO E3Z EAP EBD EBS ECM EIF EJD ELW EMB EMOBN ESX F5P FRP FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 M1O M48 NAPCQ NPM OK1 P2P PGMZT PIMPY PQQKQ RNS RPM SJN SV3 TR2 UKHRP XSB AAYXX CITATION 3V. 7QJ 7XB 8FK AZQEC COVID E3H F2A K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c457t-53d66b440778b60fad34eeb142f882a0efc60b9e6604044994e518de14a4e8d23 |
IEDL.DBID | RPM |
ISSN | 1438-8871 1439-4456 |
IngestDate | Thu Jul 04 21:10:57 EDT 2024 Tue Sep 17 21:13:43 EDT 2024 Fri Aug 16 09:43:48 EDT 2024 Wed Aug 21 08:21:34 EDT 2024 Fri Aug 23 01:41:21 EDT 2024 Sat Sep 28 08:17:17 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | research notification mechanism Lou Gehrig disease motor neuron disease National ALS Registry patient recruitment clinical trials amyotrophic lateral sclerosis |
Language | English |
License | Paul Mehta, Jaime Raymond, Moon Kwon Han, Theodore Larson, James D Berry, Sabrina Paganoni, Hiroshi Mitsumoto, Richard Stanley Bedlack, D Kevin Horton. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.12.2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c457t-53d66b440778b60fad34eeb142f882a0efc60b9e6604044994e518de14a4e8d23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0898-6081 0000-0002-0796-8861 0000-0003-4719-4829 0000-0002-2246-3618 0000-0001-6259-8923 0000-0003-4666-7495 0000-0002-5594-6931 0000-0003-0505-1168 0000-0001-6214-6687 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693186/ |
PMID | 34878988 |
PQID | 2615533506 |
PQPubID | 2033121 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_597b01e04ff4436796ffe0a31c702d0b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8693186 proquest_miscellaneous_2608452176 proquest_journals_2615533506 crossref_primary_10_2196_28021 pubmed_primary_34878988 |
PublicationCentury | 2000 |
PublicationDate | 2021-12-07 |
PublicationDateYYYYMMDD | 2021-12-07 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada – name: Toronto – name: Toronto, Canada |
PublicationTitle | Journal of medical Internet research |
PublicationTitleAlternate | J Med Internet Res |
PublicationYear | 2021 |
Publisher | Gunther Eysenbach MD MPH, Associate Professor JMIR Publications |
Publisher_xml | – name: Gunther Eysenbach MD MPH, Associate Professor – name: JMIR Publications |
References | ref13 ref12 ref15 ref14 ref31 ref30 ref11 ref10 Mehta, P (ref8) 2014; 63 ref2 ref1 ref17 Mitsumoto, H (ref3) 1998 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref7 ref9 ref4 ref6 ref5 |
References_xml | – ident: ref19 doi: 10.1111/1753-6405.12868 – ident: ref26 doi: 10.1136/bmj.d3662 – ident: ref7 – ident: ref2 doi: 10.15585/mmwr.mm6746a1 – volume: 63 start-page: 1 issue: 7 year: 2014 ident: ref8 publication-title: MMWR Suppl contributor: fullname: Mehta, P – ident: ref24 – ident: ref25 – ident: ref13 doi: 10.1080/17482960802195913 – ident: ref27 – ident: ref12 doi: 10.1080/21678421.2017.1406953 – ident: ref4 doi: 10.1002/mus.880180711 – ident: ref6 doi: 10.1016/S1474-4422(18)30091-7 – ident: ref11 – ident: ref17 – ident: ref14 doi: 10.3109/17482968.2010.484494 – ident: ref1 doi: 10.1159/000351153 – ident: ref15 doi: 10.3389/fneur.2017.00521 – ident: ref9 doi: 10.1212/wnl.0b013e3182a823e0 – ident: ref20 doi: 10.1212/WNL.0000000000006855 – ident: ref21 – ident: ref16 doi: 10.1002/mus.24421 – ident: ref28 doi: 10.15585/mmwr.ss6508a1 – year: 1998 ident: ref3 publication-title: Amyotrophic Lateral Sclerosis contributor: fullname: Mitsumoto, H – ident: ref22 doi: 10.1002/mus.26921 – ident: ref30 doi: 10.1002/mus.27091 – ident: ref5 doi: 10.1358/dot.2018.54.6.2828189 – ident: ref18 – ident: ref29 doi: 10.1212/wnl.0000000000008620 – ident: ref23 doi: 10.1038/s41581-020-00336-9 – ident: ref10 doi: 10.3389/fnagi.2017.00068 – ident: ref31 doi: 10.1016/j.cct.2014.12.012 |
SSID | ssj0020491 |
Score | 2.4067345 |
Snippet | Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges include... Background Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These... Background: Researchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These... BACKGROUNDResearchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges... BackgroundResearchers face challenges in patient recruitment, especially for rare, fatal diseases such as amyotrophic lateral sclerosis (ALS). These challenges... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e28021 |
SubjectTerms | Adolescent Adult Age Aged Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - epidemiology Amyotrophic Lateral Sclerosis - therapy Clinical research Clinical trials Clinical Trials as Topic Committees Confidentiality Disease Electronic mail systems Eligibility Epidemiologic Studies Family medical history Females Gender Hazardous materials Humans Males Middle Aged Motor neurone disease Notification Original Paper Participation Patient Selection Patients Proximity Recruitment Registries Research Design Researchers Review boards Statistical power Terminal illnesses Websites Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NatwwEBYlh1AopUn_3CZhCqW3JbIly3JvaUkIJRtKm9DcjC2PuoaNHWJvIbe-Rl-mD5Mn6UjWbrOl0EsvxljGljwj-Rvpm0-MvY4rbZM6t5Pc0kHWSrmzeFLLnFcmIy8wLsF5eqqOz-WHi_TizlZfjhM2ygOPH26fAG_FY-TSWimFm_WwFnkpYpPxpOaVH33jdBlMhVCLcG-8yR44ojO52H6ieRKv_Xm8QP_fUOWf5Mg7f5ujR-xhgIlwMFZvi93DdpvthiQDeAMhi8h9VQjdc5ttTsNC-WP208HBReMp5NBZ-DjKp_bwpRlmcHB50w3X3dWsMXBSuhzkOT1ljlTvpgd6MgS50DmceQeFsq3h8Pdmsr4oUBDfAsWu49jzDf3FG_dGApYQRLepHSef4RN-9TvL3X7_0cOS8AennScrjS2ZostDbvrLJ-z86PDs_fEkbNUwMTLNhkkqyMqVpOgw05XitqyFRHQTTJYgfMnRGsWrHJWiQUNSlCUxjXWNsSwl6joRT9lG27X4nEFJQaBJTGnS3EhMVC4wM5W1VqCT8hER21uasbgaFTkKimScnQtv54i9c8ZdFToBbX-B3KoIblX8y60itrN0jSL06r5I3CKuEClXEXu1Kqb-6BZZyha7hbuHa0mYKKN7no2etKqJoOhQ51pHLFvzsbWqrpe0zcxrfmtqeazVi__RtpfsfuKYOY6Uk-2wjeF6gbsErYZqz_eiX6xDKJM priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ra9RAEF5qhSKIaNUabcsK4lu4TXaTbHyRKi2H9Ipoi_cWks1uL3BNzktO6Jt_wz_jj_GXOLPZ3HkivoSQDcluZmbzze43M4S8CgppwjI1fmrgIMo4xrPAL0XKCpWAFigMcJ5cxOMr8WEaTXfIeIiFQVrlMCfaibpsFK6Rj0LcQOM8YvEoL3AVQHWjt4uvPtaPwn1WV0zjDrkbhAArQLOT6cb1Ahwc7JH7SHwGlRuFkoXB1p_IJuz_F8r8myz5x9_n7CF54GAjPenl_Ijs6HqfHLmgA_qauqgi_MrUmes-2Zu4jfPH5CfCw1VlKeW0MfRjn061pV-qbkZPbm6bbtksZpWi5znGJM_hKXMN_a5aCk-mLn3onF5ahaV5XdLTTXFZ2-QoiW8o-LL9XPRN24u3-EYAmtQl4YZxnH-mn_S1rTT36_uPlg4EQHrRWPJSP5KJxrjkqr15Qq7OTi_fj31XusFXIko6P-Ig9UKAt5jIImYmL7nQGhecDED6nGmjYlakOo5hEhHgdQkdBbLUgciFlmXIn5Lduqn1M0JzcApVqHIVpUroME65TlRhjOEaU_twjxwPYswWfYaODDwblHNm5eyRdyjcdSMm1LYXmuV15uwzA7-qYIFmwhghOC6uGaNZzgOVsLBkhUcOB9XInJW32UYnPfJy3Qz2iZsuea2bFd7DpACMlMA9B70mrXvCwVuUqZQeSbZ0bKur2y11NbM5wCWMPJDx8_936wW5FyIHB-k3ySHZ7ZYrfQQgqiuOrX38BudHJBM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fi9QwEA9ywiGI6Pnn9v4RQXyrpk2apoLIKXcccnuI3qJvpU2T28Jee2674r75Nfwyfhg_iTNpdr3K4UspTUgnmZlkJvnNhJBnYaFsVKY2SC08RCklvoVBKVJW6ASkQGOA8_hMnkzE-y_xNTShH8D2RtcO75OazGcvvn9dvgGFf40wZhCgl5FiGEp-OxJcoJCPxfogIQIDONwkdwdVB0uQy9R_k3n5L0ry2rJzfJ_c8_YiPewZ_IDcMvUW2ffRBvQ59eFEOLzU6-kW2Rz7E_OH5BfahYvKYclpY-mHPo9qSz9X3ZQeXi6bbt5cTStNT3MMRp5BKzMDdFcthZapzxs6o-dOUmlel_To762yrshjEV9RcGL7SeibcR-X-EewMKnPvg39OP1EP5oLd8Xc7x8_W7pC_tGzxqGW-p6MDQYkV-3lIzI5Pjp_dxL4OxsCLeKkC2IO7C4EuImJKiSzecmFMbjTZMGWz5mxWrIiNVLC7CHA3RImDlVpQpELo8qIPyYbdVObbUJz8AZ1pHMdp1qYSKbcJLqw1nKDOX34iBys2Jhd9ak5MnBpkM-Z4_OIvEXmrgsxk7b70MwvMq-YGThUBQsNE9YKwXFXzVrDch7qhEUlK0ZkbyUa2Uo6swhPczmPmRyRp-tiUEw8bclr0yywDlMCjKME6jzpJWlNCQc3UaVKjUgykLEBqcOSupq65N8Keh4qufN_snbJnQjBN4i7SfbIRjdfmH2wnrriwOnHH5kYIL0 priority: 102 providerName: Scholars Portal |
Title | Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34878988 https://www.proquest.com/docview/2615533506/abstract/ https://search.proquest.com/docview/2608452176 https://pubmed.ncbi.nlm.nih.gov/PMC8693186 https://doaj.org/article/597b01e04ff4436796ffe0a31c702d0b |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD7ahlRNQgjGLbBVRkK8dXVi58bbVjoNtHbV2KBvUeLYa6Q2qXpB2ht_gz_Dj-GXcOw4HUU88eJEcS5Ozjnxd-zvHAO8dbNIeXmsOrHCgudBoPfcTs5jmokQtUDoAOfBMDi_4Z_G_ngH_CYWxpD2RVYcl9PZcVlMDLdyPhPdhifWHQ16URCjKgbdXdgNGWtcdOtlIeQ1XhbXU5wID1rwUPOdUdO6XoQ92j60GKL0KDaLrdz3RSZl_79w5t90yT_6n7PH8MgCR3JSN_AJ7MjyAI5s2AF5R2xckf7OxBrsAbQGdur8KfzUAHFdGFI5qRQZ1QlVl-RrsZqQk9ldtVpU80khyEWqo5KneJepxHYXS4J3JjaB6JRcG5UlaZmT_v3ysqbKkhLfE_Rm67_RN2kO3uknItQkNg03vsfFZ3Ilb81ac7--_1iShgJIhpWhL9VvMpA6MrlYzp7BzVn_unfesYs3dAT3w1XHZyj3jKO_GEZZQFWaMy6lHnJSCOpTKpUIaBbLIMDfCEe_i0vfjXLp8pTLKPfYc9grq1K-BJKiWyg8kQo_Flx6KHwZikwpxaRO7sMcaDdiTOZ1jo4EfRst8sSI3IFTLdxNpU6pbQ5Ui9vEKlaCnlVGXUm5UpwzPbymlKQpc0VIvZxmDhw2qpFYO18mnp7WZcyngQNvNtVooXraJS1ltdbn0IgjSgrxnBe1Jm1a0miiA-GWjm01dbsGjcJkAbdG8Oq_r3wN-54m6GhuTngIe6vFWh4hwlplbbSrcdiGB6f94egKt73LLx8_tM14BZYD91KXPGoby_sN5PQyPQ |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,11965,12083,21416,24346,27957,27958,31754,31755,33779,33780,36210,36211,38551,43345,43840,43930,44421,74102,74659,74769,75275 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELdgSANpQjD-FbZhJMRbNCd2EocXNNCmAm2FoBN9ixLHXiN1SdekSHvja_Bl-DB8Eu4ct6UI8RJFtuXYuTv7zv7dHSEv_VyaoEiMlxh4iCKK8M33CpGwXMXABQodnIejqH8uPkzCiTtwaxyscrUm2oW6qBWekR8HeIHGeciiN_MrD7NG4e2qS6Fxk9wSnAuE9MWTjcEF2q-_S_YQ7gyMdhxIFvhb-48N0_8v3fJviOQfe87ZPXLXKYv0pKPufXJDV_vk0Lka0FfU-RLhv6VOSPfJ7tBdlz8gP1EpXJYWSE5rQz91QVQb-rVsp_Tk8rpuF_V8Wio6yNATeQa9zDSMu2wo9Exd0NAZHVs2pVlV0NNNSllb5YCIrylYsN0K9E3bwmv8IqiX1IXehnkMvtDP-sLml_v1_UdDV7A_OqotZKmbyVCjN3LZXD4k52en43d9zyVs8JQI49YLOdA6F2AjxjKPmMkKLrTGYyYDinzGtFERyxMdRbB0CLC1hA59WWhfZELLIuCPyE5VV_oJoRmYgipQmQoTJXQQJVzHKjfGcI0BfXiPHK3ImM67uBwp2DNI59TSuUfeInHXlRhG2xbUi4vUSWUK1lTOfM2EMUJwPFIzRrOM-ypmQcHyHjlYsUbqZLtJN5zYIy_W1SCVeNWSVbpeYhsmBWhGMbR53HHSeiQcbESZSNkj8RaPbQ11u6Yqpzbyt4SZ-zJ6-v9hPSe3--PhIB28H318Ru4EiMJBAE58QHbaxVIfghrV5kdWVn4DS0wjRg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELdgkyokhGD8K2zDSIi3qE7sJA4vaINWA9qqGpvYW5Q49hqpS0rTIu2Nr8GX4cPwSbhz3I4ixEsU2ZZj5-7sO_t3d4S88nNpgiIxXmLgIYoowjffK0TCchUDFyh0cB6No5Nz8fEivHD4p8bBKtdrol2oi1rhGXkvwAs0zkMW9YyDRUzeD97Ov3qYQQpvWl06jdtkNxZRCBy-e9wfT0435hfown6H3EXwM7BdL5As8Ld2Ixu0_1-a5t-AyT92oMF9cs-pjvSopfUDcktXe-TAOR7Q19R5FuGfpk5k90hn5C7PH5KfqCKuSgsrp7WhkzakakO_lMspPbq6rpeLej4tFR1m6Jc8g15mGsZdNhR6pi6E6IyeWaalWVXQ_k2CWVvlYIlvKNiz7Xr0TdvCa_wiKJvUBeKGeQw_01N9abPN_fr-o6FrECAd1xbA1M5kpNE3uWyuHpHzQf_s3Ynn0jd4SoTx0gs5UD4XYDHGMo-YyQoutMZDJwNqfca0URHLEx1FsJAIsLyEDn1ZaF9kQssi4I_JTlVX-imhGRiGKlCZChMldBAlXMcqN8ZwjeF9eJccrsmYztsoHSlYN0jn1NK5S46RuJtKDKptC-rFZepkNAXbKme-ZsIYITgesBmjWcZ9FbOgYHmX7K9ZI3WS3qQ3fNklLzfVIKN48ZJVul5hGyYF6EkxtHnSctJmJBwsRplI2SXxFo9tDXW7piqnNg64hJn7Mnr2_2G9IB0QlHT4YfzpObkTICQH0TjxPtlZLlb6AHSqZX7ohOU3lAIo6Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recruitment+of+Patients+With+Amyotrophic+Lateral+Sclerosis+for+Clinical+Trials+and+Epidemiological+Studies%3A+Descriptive+Study+of+the+National+ALS+Registry%E2%80%99s+Research+Notification+Mechanism&rft.jtitle=Journal+of+medical+Internet+research&rft.au=Mehta%2C+Paul&rft.au=Raymond%2C+Jaime&rft.au=Moon+Kwon+Han&rft.au=Larson%2C+Theodore&rft.date=2021-12-07&rft.pub=Gunther+Eysenbach+MD+MPH%2C+Associate+Professor&rft.eissn=1438-8871&rft.spage=e28021&rft_id=info:doi/10.2196%2F28021&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1438-8871&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1438-8871&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1438-8871&client=summon |